Stefan Loren
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Stefan D.
Loren is the founder of Loren Capital Strategy LLC, founded in 2014.
Current jobs include Managing Director at Oppenheimer & Co., Inc. since 2017, Independent Director at Cellectar Biosciences, Inc. since 2015, and Advisory Board member at Prevail Partners LLC.
Former jobs include Managing Director-Healthcare Group at Legg Mason, Inc. from 1997 to 2005, Board Director at GenVec, Inc. from 2013 to 2017, Director at Orchid Cellmark, Inc., Director at PolyMedix, Inc. from 2008 to 2011, Managing Director at Legg Mason Wood Walker, Inc. in 2005, Alumni Board Director at the University of California San Diego from 2010 to 2015, Lead Independent Director at Adhera Therapeutics, Inc. from 2012 to 2017, Managing Director at Westwicke Partners LLC from 2008 to 2014, Research Chemist-Advanced Technologies Division at Abbott Laboratories, Board Member at Orchid Cellmark, Inc. from 2010 to 2011, Analyst at Perceptive Advisors LLC from 2007 to 2008, Board member at Adhera Therapeutics, Inc., Advisor at Numoda Capital Innovations LLC, and Portfolio Manager at MTB Investment Advisors, Inc. Education includes a doctorate from the University of California, Berkeley, conferred in 1992, and an undergraduate degree from the University of California San Diego, conferred in 1987.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Directeur/Membre du Conseil | 15/06/2015 |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Private Equity Investor | 01/11/2017 |
Prevail Partners LLC
Prevail Partners LLC Investment ManagersFinance Prevail Partners invests in companies located in the United States. The firm focuses on life sciences companies such as those in healthcare therapies, preventive treatments, medical devices and diagnostics. It participates in early-stage capital requirements. | Consultant / Advisor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/10/2017 |
| GENVEC INC | Directeur/Membre du Conseil | 16/06/2017 |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 01/09/2015 |
Westwicke Partners LLC
Westwicke Partners LLC Investment ManagersFinance Provides investment advisory and management consulting services | Private Equity Investor | 01/02/2014 |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Directeur/Membre du Conseil | 01/12/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 17 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Legg Mason, Inc.
Legg Mason, Inc. Investment ManagersFinance Provides investment and asset management services | Finance |
GenVec, Inc.
GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
PolyMedix, Inc.
PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
Legg Mason Wood Walker, Inc.
Legg Mason Wood Walker, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adhera Therapeutics, Inc.
Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Numoda Capital Innovations LLC
Numoda Capital Innovations LLC Investment ManagersFinance Numoda Capital invests in companies located in the United States. The firm focuses on a life sciences companies. It provides financing for early stage capital requirements. | Finance |
Westwicke Partners LLC
Westwicke Partners LLC Investment ManagersFinance Provides investment advisory and management consulting services | Finance |
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Prevail Partners LLC
Prevail Partners LLC Investment ManagersFinance Prevail Partners invests in companies located in the United States. The firm focuses on life sciences companies such as those in healthcare therapies, preventive treatments, medical devices and diagnostics. It participates in early-stage capital requirements. | Finance |
Loren Capital Strategy LLC | |
MTB Investment Advisors, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national